Adicet Bio, Inc. 8-K

What Happened

• On May 13, 2026, Adicet Bio, Inc. announced its quarterly financial results for the quarter ended March 31, 2026 by furnishing a press release as Exhibit 99.1 to a Form 8-K (Item 2.02). The Form 8-K notes that the information and the press release are being furnished — not filed — under the Exchange Act. The report is signed by Nick Harvey, Chief Financial Officer.

Key Details

• Filing date: May 13, 2026 (Form 8-K, Item 2.02).
• Reporting period: Quarter ended March 31, 2026 (Q1 2026).
• Exhibit: Press release furnished as Exhibit 99.1 to the 8-K.
• Legal note: Information furnished and not “filed” under Section 18 of the Exchange Act (limits certain liabilities).

Why It Matters

• This 8-K signals that Adicet has released its latest quarterly results (earnings/quarterly results). Retail investors should review the Exhibit 99.1 press release for revenue, profit/loss, cash runway, and any commentary on operations or outlook. Because the release is furnished (not filed), investors should also watch for the company’s upcoming Form 10-Q or other filings for the complete, detailed financial statements and disclosures.